---
title: "GOLDBERG OFER — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914
json: https://whiteintel.dev/api/public/dossier/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914
identifier: sec:0001466892
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GOLDBERG OFER

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001466892`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914  

## Ownership & control

### Holdings / subsidiaries

- **BIOCANCELL THERAPEUTICS INC.** (director) — https://whiteintel.dev/entity/a8dbc465-8648-5e6f-91b1-97c82ec4924a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GOLDBERG OFER**. Human view: https://whiteintel.dev/entity/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914 · Structured JSON: https://whiteintel.dev/api/public/dossier/6f30eb8b-aca4-5274-b4dc-9c8dbcd4d914._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._